EHG Highlights of 2017

“The choices that women make have huge impact on families, on communities and on nations. Being able to provide an enabling environment for them to exercise their rights and make choices in their lives is crucial. It is at the heart of human development!” - Dr Babatunde Osotimehin

I am excited and delighted to share a look back at some of the highlights from the past year. 2017 was yet another year of expanding our horizons, with new projects, new clients, new countries and new staff. It was also a time to bid a happy retirement to one of the EHG family, Susanne Andersen and farewell to all our GMS colleagues.

Throughout the year, we continued to focus on providing quality services within our four key areas of health systems development, HIV & AIDS, sexual and reproductive health and rights, monitoring and evaluation, and pharmaceutical management. We excelled in the conduct of complex, multi-country evaluations of health interventions, with considerable emphasis on maternal, child, newborn and adolescent health and gender. It was a pleasure to work with, in addition to others, UNICEF, SDC and LuxDev as new clients.

Our longstanding relationship with the Global Fund to fight AIDS, Tuberculosis and Malaria persisted, adding to our portfolio the long-term Prospective Country Evaluation (PCE) assignment targeting three countries. EHG, together with Itad and UCSF in addition to country partners in Sudan (Blue Nile National Institute for Communicable Diseases), Myanmar (Myanmar Knowledge Management Foundation) and Cambodia (Angkor Research and Consulting) started the PCE three-year journey to enable more in-depth, real-time monitoring and evaluation, learning and problem-solving. This will assist with programme adaptation and measurement of impact on behalf of the Global Fund under the project.

We also conducted a gender review for the Global Fund and SR2017 together with Itad where we assessed progress of the previous strategy and analysed how lessons learned are contributing to the implementation of the 2017–2022 strategy. Other projects for the Global Fund included a programmatic assurance review, evaluation of the Rwanda National Strategy Financing (NSF) model and a sustainability and transition technical assistance framework contract.

As an organisation, we continued our commitment to evaluating the impact of public health initiatives. We wrapped up the Endline Evaluation of the H4+ Joint Programme Canada and Sweden for UNPFA, the Evaluation of the RMNCH Trust Fund for UNICEF, phase I (mid-term) Evaluation of the Millennium Development Goal Initiative (MDGi) for the EU in Zambia, and kicked off the UNFPA Supplies Evaluation.

We have expanded our geographic focus to include assignments in 45+ countries over the past five years. Some of our new countries and clients have included: LuxDev in Lao PDR, where we provided technical assistance on a risk analysis and developed a risk mitigation plan for HIV, tuberculosis and malaria Global Fund grants; and the Swiss Development Cooperation in Kyrgyzstan, where along with GFA as the lead we have engaged in a long-term project focusing on strengthening governance in the primary health care system.

The team at EHG is passionate and committed to improving global health and to working in a participatory, transparent and fair manner with our technical consultants, clients and beneficiaries. One of our longterm consultants told us this year that "EHG is my consulting organisation of choice because one truly feels that its team is dedicated to achieve and reach out way beyond their own interest. One can clearly see that it is a women-led organisation: inclusive, resourceful and pragmatic."

I am delighted to share a look back at some of the highlights of the year and personally proud of what we have achieved and will continue to achieve in the years to come.

In closing, I would like to say a fond farewell to one of the champions for women, adolescent and youth health, Dr. Babatunde Osotimehin, former head of the United Nations Population Fund. Dr Osotimehin provided leadership and fought to ensure that the rights of women and girls were high on the global agenda. He did this through a commitment, in part, to end maternal death, address unmet need for family planning and put an end to harmful practices against women and girls. His presence is missed but his legacy remains. 

Michele Gross, CEO